Global Immune Thrombocytopenic Purpura Therapeutics Market Insights, Forecast To 2028

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immune Thrombocytopenic Purpura Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Eltrombopag Olamine
1.2.3 Fostamatinib Disodium
1.2.4 GL-2045
1.2.5 Avatrombopag
1.2.6 BI-655064
1.2.7 Others
1.3 Market by Application
1.3.1 Global Immune Thrombocytopenic Purpura Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Immune Thrombocytopenic Purpura Therapeutics Market Perspective (2017-2028)
2.2 Immune Thrombocytopenic Purpura Therapeutics Growth Trends by Region
2.2.1 Immune Thrombocytopenic Purpura Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Immune Thrombocytopenic Purpura Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Immune Thrombocytopenic Purpura Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Immune Thrombocytopenic Purpura Therapeutics Market Dynamics
2.3.1 Immune Thrombocytopenic Purpura Therapeutics Industry Trends
2.3.2 Immune Thrombocytopenic Purpura Therapeutics Market Drivers
2.3.3 Immune Thrombocytopenic Purpura Therapeutics Market Challenges
2.3.4 Immune Thrombocytopenic Purpura Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immune Thrombocytopenic Purpura Therapeutics Players by Revenue
3.1.1 Global Top Immune Thrombocytopenic Purpura Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Immune Thrombocytopenic Purpura Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immune Thrombocytopenic Purpura Therapeutics Revenue
3.4 Global Immune Thrombocytopenic Purpura Therapeutics Market Concentration Ratio
3.4.1 Global Immune Thrombocytopenic Purpura Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immune Thrombocytopenic Purpura Therapeutics Revenue in 2021
3.5 Immune Thrombocytopenic Purpura Therapeutics Key Players Head office and Area Served
3.6 Key Players Immune Thrombocytopenic Purpura Therapeutics Product Solution and Service
3.7 Date of Enter into Immune Thrombocytopenic Purpura Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immune Thrombocytopenic Purpura Therapeutics Breakdown Data by Type
4.1 Global Immune Thrombocytopenic Purpura Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Immune Thrombocytopenic Purpura Therapeutics Forecasted Market Size by Type (2023-2028)
5 Immune Thrombocytopenic Purpura Therapeutics Breakdown Data by Application
5.1 Global Immune Thrombocytopenic Purpura Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Immune Thrombocytopenic Purpura Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Immune Thrombocytopenic Purpura Therapeutics Market Size (2017-2028)
6.2 North America Immune Thrombocytopenic Purpura Therapeutics Market Size by Type
6.2.1 North America Immune Thrombocytopenic Purpura Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Immune Thrombocytopenic Purpura Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Immune Thrombocytopenic Purpura Therapeutics Market Share by Type (2017-2028)
6.3 North America Immune Thrombocytopenic Purpura Therapeutics Market Size by Application
6.3.1 North America Immune Thrombocytopenic Purpura Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Immune Thrombocytopenic Purpura Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Immune Thrombocytopenic Purpura Therapeutics Market Share by Application (2017-2028)
6.4 North America Immune Thrombocytopenic Purpura Therapeutics Market Size by Country
6.4.1 North America Immune Thrombocytopenic Purpura Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Immune Thrombocytopenic Purpura Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Immune Thrombocytopenic Purpura Therapeutics Market Size (2017-2028)
7.2 Europe Immune Thrombocytopenic Purpura Therapeutics Market Size by Type
7.2.1 Europe Immune Thrombocytopenic Purpura Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Immune Thrombocytopenic Purpura Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Immune Thrombocytopenic Purpura Therapeutics Market Share by Type (2017-2028)
7.3 Europe Immune Thrombocytopenic Purpura Therapeutics Market Size by Application
7.3.1 Europe Immune Thrombocytopenic Purpura Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Immune Thrombocytopenic Purpura Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Immune Thrombocytopenic Purpura Therapeutics Market Share by Application (2017-2028)
7.4 Europe Immune Thrombocytopenic Purpura Therapeutics Market Size by Country
7.4.1 Europe Immune Thrombocytopenic Purpura Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Immune Thrombocytopenic Purpura Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size by Type
8.2.1 Asia-Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Immune Thrombocytopenic Purpura Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size by Application
8.3.1 Asia-Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Immune Thrombocytopenic Purpura Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size by Region
8.4.1 Asia-Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Immune Thrombocytopenic Purpura Therapeutics Market Size (2017-2028)
9.2 Latin America Immune Thrombocytopenic Purpura Therapeutics Market Size by Type
9.2.1 Latin America Immune Thrombocytopenic Purpura Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Immune Thrombocytopenic Purpura Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Immune Thrombocytopenic Purpura Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Immune Thrombocytopenic Purpura Therapeutics Market Size by Application
9.3.1 Latin America Immune Thrombocytopenic Purpura Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Immune Thrombocytopenic Purpura Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Immune Thrombocytopenic Purpura Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Immune Thrombocytopenic Purpura Therapeutics Market Size by Country
9.4.1 Latin America Immune Thrombocytopenic Purpura Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Immune Thrombocytopenic Purpura Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immune Thrombocytopenic Purpura Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Immune Thrombocytopenic Purpura Therapeutics Market Size by Type
10.2.1 Middle East & Africa Immune Thrombocytopenic Purpura Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Immune Thrombocytopenic Purpura Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Immune Thrombocytopenic Purpura Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Immune Thrombocytopenic Purpura Therapeutics Market Size by Application
10.3.1 Middle East & Africa Immune Thrombocytopenic Purpura Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Immune Thrombocytopenic Purpura Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Immune Thrombocytopenic Purpura Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Immune Thrombocytopenic Purpura Therapeutics Market Size by Country
10.4.1 Middle East & Africa Immune Thrombocytopenic Purpura Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Immune Thrombocytopenic Purpura Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Details
11.1.2 Amgen Inc. Business Overview
11.1.3 Amgen Inc. Immune Thrombocytopenic Purpura Therapeutics Introduction
11.1.4 Amgen Inc. Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
11.1.5 Amgen Inc. Recent Developments
11.2 Baxalta Incorporated
11.2.1 Baxalta Incorporated Company Details
11.2.2 Baxalta Incorporated Business Overview
11.2.3 Baxalta Incorporated Immune Thrombocytopenic Purpura Therapeutics Introduction
11.2.4 Baxalta Incorporated Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
11.2.5 Baxalta Incorporated Recent Developments
11.3 Boehringer Ingelheim GmbH
11.3.1 Boehringer Ingelheim GmbH Company Details
11.3.2 Boehringer Ingelheim GmbH Business Overview
11.3.3 Boehringer Ingelheim GmbH Immune Thrombocytopenic Purpura Therapeutics Introduction
11.3.4 Boehringer Ingelheim GmbH Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
11.3.5 Boehringer Ingelheim GmbH Recent Developments
11.4 Bristol-Myers Squibb Company
11.4.1 Bristol-Myers Squibb Company Company Details
11.4.2 Bristol-Myers Squibb Company Business Overview
11.4.3 Bristol-Myers Squibb Company Immune Thrombocytopenic Purpura Therapeutics Introduction
11.4.4 Bristol-Myers Squibb Company Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
11.4.5 Bristol-Myers Squibb Company Recent Developments
11.5 Eisai
11.5.1 Eisai Company Details
11.5.2 Eisai Business Overview
11.5.3 Eisai Immune Thrombocytopenic Purpura Therapeutics Introduction
11.5.4 Eisai Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
11.5.5 Eisai Recent Developments
11.6 Hansa Medical AB
11.6.1 Hansa Medical AB Company Details
11.6.2 Hansa Medical AB Business Overview
11.6.3 Hansa Medical AB Immune Thrombocytopenic Purpura Therapeutics Introduction
11.6.4 Hansa Medical AB Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
11.6.5 Hansa Medical AB Recent Developments
11.7 Immunomedics, Inc.
11.7.1 Immunomedics, Inc. Company Details
11.7.2 Immunomedics, Inc. Business Overview
11.7.3 Immunomedics, Inc. Immune Thrombocytopenic Purpura Therapeutics Introduction
11.7.4 Immunomedics, Inc. Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
11.7.5 Immunomedics, Inc. Recent Developments
11.8 Intas Pharmaceuticals Ltd.
11.8.1 Intas Pharmaceuticals Ltd. Company Details
11.8.2 Intas Pharmaceuticals Ltd. Business Overview
11.8.3 Intas Pharmaceuticals Ltd. Immune Thrombocytopenic Purpura Therapeutics Introduction
11.8.4 Intas Pharmaceuticals Ltd. Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
11.8.5 Intas Pharmaceuticals Ltd. Recent Developments
11.9 Jiangsu Hengrui Medicine Co., Ltd.
11.9.1 Jiangsu Hengrui Medicine Co., Ltd. Company Details
11.9.2 Jiangsu Hengrui Medicine Co., Ltd. Business Overview
11.9.3 Jiangsu Hengrui Medicine Co., Ltd. Immune Thrombocytopenic Purpura Therapeutics Introduction
11.9.4 Jiangsu Hengrui Medicine Co., Ltd. Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
11.9.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
11.10 Merck & Co., Inc.
11.10.1 Merck & Co., Inc. Company Details
11.10.2 Merck & Co., Inc. Business Overview
11.10.3 Merck & Co., Inc. Immune Thrombocytopenic Purpura Therapeutics Introduction
11.10.4 Merck & Co., Inc. Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
11.10.5 Merck & Co., Inc. Recent Developments
11.11 Momenta Pharmaceuticals, Inc.
11.11.1 Momenta Pharmaceuticals, Inc. Company Details
11.11.2 Momenta Pharmaceuticals, Inc. Business Overview
11.11.3 Momenta Pharmaceuticals, Inc. Immune Thrombocytopenic Purpura Therapeutics Introduction
11.11.4 Momenta Pharmaceuticals, Inc. Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
11.11.5 Momenta Pharmaceuticals, Inc. Recent Developments
11.12 Novartis AG
11.12.1 Novartis AG Company Details
11.12.2 Novartis AG Business Overview
11.12.3 Novartis AG Immune Thrombocytopenic Purpura Therapeutics Introduction
11.12.4 Novartis AG Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
11.12.5 Novartis AG Recent Developments
11.13 Pfizer Inc.
11.13.1 Pfizer Inc. Company Details
11.13.2 Pfizer Inc. Business Overview
11.13.3 Pfizer Inc. Immune Thrombocytopenic Purpura Therapeutics Introduction
11.13.4 Pfizer Inc. Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
11.13.5 Pfizer Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Immune Thrombocytopenic Purpura Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Eltrombopag Olamine
Table 3. Key Players of Fostamatinib Disodium
Table 4. Key Players of GL-2045
Table 5. Key Players of Avatrombopag
Table 6. Key Players of BI-655064
Table 7. Key Players of Others
Table 8. Global Immune Thrombocytopenic Purpura Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 9. Global Immune Thrombocytopenic Purpura Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Immune Thrombocytopenic Purpura Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Immune Thrombocytopenic Purpura Therapeutics Market Share by Region (2017-2022)
Table 12. Global Immune Thrombocytopenic Purpura Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Immune Thrombocytopenic Purpura Therapeutics Market Share by Region (2023-2028)
Table 14. Immune Thrombocytopenic Purpura Therapeutics Market Trends
Table 15. Immune Thrombocytopenic Purpura Therapeutics Market Drivers
Table 16. Immune Thrombocytopenic Purpura Therapeutics Market Challenges
Table 17. Immune Thrombocytopenic Purpura Therapeutics Market Restraints
Table 18. Global Immune Thrombocytopenic Purpura Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Immune Thrombocytopenic Purpura Therapeutics Revenue Share by Players (2017-2022)
Table 20. Global Top Immune Thrombocytopenic Purpura Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Thrombocytopenic Purpura Therapeutics as of 2021)
Table 21. Ranking of Global Top Immune Thrombocytopenic Purpura Therapeutics Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Immune Thrombocytopenic Purpura Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Immune Thrombocytopenic Purpura Therapeutics Product Solution and Service
Table 25. Date of Enter into Immune Thrombocytopenic Purpura Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Immune Thrombocytopenic Purpura Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share by Type (2017-2022)
Table 29. Global Immune Thrombocytopenic Purpura Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share by Type (2023-2028)
Table 31. Global Immune Thrombocytopenic Purpura Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Immune Thrombocytopenic Purpura Therapeutics Revenue Share by Application (2017-2022)
Table 33. Global Immune Thrombocytopenic Purpura Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Immune Thrombocytopenic Purpura Therapeutics Revenue Share by Application (2023-2028)
Table 35. North America Immune Thrombocytopenic Purpura Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 36. North America Immune Thrombocytopenic Purpura Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 37. North America Immune Thrombocytopenic Purpura Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 38. North America Immune Thrombocytopenic Purpura Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 39. North America Immune Thrombocytopenic Purpura Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 40. North America Immune Thrombocytopenic Purpura Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 41. Europe Immune Thrombocytopenic Purpura Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 42. Europe Immune Thrombocytopenic Purpura Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 43. Europe Immune Thrombocytopenic Purpura Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 44. Europe Immune Thrombocytopenic Purpura Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 45. Europe Immune Thrombocytopenic Purpura Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 46. Europe Immune Thrombocytopenic Purpura Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 47. Asia Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 48. Asia Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 49. Asia Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 50. Asia Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 51. Asia Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 52. Asia Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 53. Latin America Immune Thrombocytopenic Purpura Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 54. Latin America Immune Thrombocytopenic Purpura Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 55. Latin America Immune Thrombocytopenic Purpura Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 56. Latin America Immune Thrombocytopenic Purpura Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 57. Latin America Immune Thrombocytopenic Purpura Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 58. Latin America Immune Thrombocytopenic Purpura Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Immune Thrombocytopenic Purpura Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Immune Thrombocytopenic Purpura Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Immune Thrombocytopenic Purpura Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Immune Thrombocytopenic Purpura Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Immune Thrombocytopenic Purpura Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Immune Thrombocytopenic Purpura Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 65. Amgen Inc. Company Details
Table 66. Amgen Inc. Business Overview
Table 67. Amgen Inc. Immune Thrombocytopenic Purpura Therapeutics Product
Table 68. Amgen Inc. Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022) & (US$ Million)
Table 69. Amgen Inc. Recent Developments
Table 70. Baxalta Incorporated Company Details
Table 71. Baxalta Incorporated Business Overview
Table 72. Baxalta Incorporated Immune Thrombocytopenic Purpura Therapeutics Product
Table 73. Baxalta Incorporated Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022) & (US$ Million)
Table 74. Baxalta Incorporated Recent Developments
Table 75. Boehringer Ingelheim GmbH Company Details
Table 76. Boehringer Ingelheim GmbH Business Overview
Table 77. Boehringer Ingelheim GmbH Immune Thrombocytopenic Purpura Therapeutics Product
Table 78. Boehringer Ingelheim GmbH Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022) & (US$ Million)
Table 79. Boehringer Ingelheim GmbH Recent Developments
Table 80. Bristol-Myers Squibb Company Company Details
Table 81. Bristol-Myers Squibb Company Business Overview
Table 82. Bristol-Myers Squibb Company Immune Thrombocytopenic Purpura Therapeutics Product
Table 83. Bristol-Myers Squibb Company Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022) & (US$ Million)
Table 84. Bristol-Myers Squibb Company Recent Developments
Table 85. Eisai Company Details
Table 86. Eisai Business Overview
Table 87. Eisai Immune Thrombocytopenic Purpura Therapeutics Product
Table 88. Eisai Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022) & (US$ Million)
Table 89. Eisai Recent Developments
Table 90. Hansa Medical AB Company Details
Table 91. Hansa Medical AB Business Overview
Table 92. Hansa Medical AB Immune Thrombocytopenic Purpura Therapeutics Product
Table 93. Hansa Medical AB Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022) & (US$ Million)
Table 94. Hansa Medical AB Recent Developments
Table 95. Immunomedics, Inc. Company Details
Table 96. Immunomedics, Inc. Business Overview
Table 97. Immunomedics, Inc. Immune Thrombocytopenic Purpura Therapeutics Product
Table 98. Immunomedics, Inc. Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022) & (US$ Million)
Table 99. Immunomedics, Inc. Recent Developments
Table 100. Intas Pharmaceuticals Ltd. Company Details
Table 101. Intas Pharmaceuticals Ltd. Business Overview
Table 102. Intas Pharmaceuticals Ltd. Immune Thrombocytopenic Purpura Therapeutics Product
Table 103. Intas Pharmaceuticals Ltd. Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022) & (US$ Million)
Table 104. Intas Pharmaceuticals Ltd. Recent Developments
Table 105. Jiangsu Hengrui Medicine Co., Ltd. Company Details
Table 106. Jiangsu Hengrui Medicine Co., Ltd. Business Overview
Table 107. Jiangsu Hengrui Medicine Co., Ltd. Immune Thrombocytopenic Purpura Therapeutics Product
Table 108. Jiangsu Hengrui Medicine Co., Ltd. Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022) & (US$ Million)
Table 109. Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
Table 110. Merck & Co., Inc. Company Details
Table 111. Merck & Co., Inc. Business Overview
Table 112. Merck & Co., Inc. Immune Thrombocytopenic Purpura Therapeutics Product
Table 113. Merck & Co., Inc. Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022) & (US$ Million)
Table 114. Merck & Co., Inc. Recent Developments
Table 115. Momenta Pharmaceuticals, Inc. Company Details
Table 116. Momenta Pharmaceuticals, Inc. Business Overview
Table 117. Momenta Pharmaceuticals, Inc. Immune Thrombocytopenic Purpura Therapeutics Product
Table 118. Momenta Pharmaceuticals, Inc. Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022) & (US$ Million)
Table 119. Momenta Pharmaceuticals, Inc. Recent Developments
Table 120. Novartis AG Company Details
Table 121. Novartis AG Business Overview
Table 122. Novartis AG Immune Thrombocytopenic Purpura Therapeutics Product
Table 123. Novartis AG Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022) & (US$ Million)
Table 124. Novartis AG Recent Developments
Table 125. Pfizer Inc. Company Details
Table 126. Pfizer Inc. Business Overview
Table 127. Pfizer Inc. Immune Thrombocytopenic Purpura Therapeutics Product
Table 128. Pfizer Inc. Revenue in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022) & (US$ Million)
Table 129. Pfizer Inc. Recent Developments
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immune Thrombocytopenic Purpura Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Eltrombopag Olamine Features
Figure 3. Fostamatinib Disodium Features
Figure 4. GL-2045 Features
Figure 5. Avatrombopag Features
Figure 6. BI-655064 Features
Figure 7. Others Features
Figure 8. Global Immune Thrombocytopenic Purpura Therapeutics Market Share by Application: 2021 VS 2028
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Immune Thrombocytopenic Purpura Therapeutics Report Years Considered
Figure 13. Global Immune Thrombocytopenic Purpura Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Immune Thrombocytopenic Purpura Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Immune Thrombocytopenic Purpura Therapeutics Market Share by Region: 2021 VS 2028
Figure 16. Global Immune Thrombocytopenic Purpura Therapeutics Market Share by Players in 2021
Figure 17. Global Top Immune Thrombocytopenic Purpura Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Thrombocytopenic Purpura Therapeutics as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Immune Thrombocytopenic Purpura Therapeutics Revenue in 2021
Figure 19. North America Immune Thrombocytopenic Purpura Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 20. North America Immune Thrombocytopenic Purpura Therapeutics Market Size Market Share by Type (2017-2028)
Figure 21. North America Immune Thrombocytopenic Purpura Therapeutics Market Size Market Share by Application (2017-2028)
Figure 22. North America Immune Thrombocytopenic Purpura Therapeutics Market Size Share by Country (2017-2028)
Figure 23. United States Immune Thrombocytopenic Purpura Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Immune Thrombocytopenic Purpura Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Immune Thrombocytopenic Purpura Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 26. Europe Immune Thrombocytopenic Purpura Therapeutics Market Size Market Share by Type (2017-2028)
Figure 27. Europe Immune Thrombocytopenic Purpura Therapeutics Market Size Market Share by Application (2017-2028)
Figure 28. Europe Immune Thrombocytopenic Purpura Therapeutics Market Size Share by Country (2017-2028)
Figure 29. Germany Immune Thrombocytopenic Purpura Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France Immune Thrombocytopenic Purpura Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. Immune Thrombocytopenic Purpura Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy Immune Thrombocytopenic Purpura Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia Immune Thrombocytopenic Purpura Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries Immune Thrombocytopenic Purpura Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size Market Share by Type (2017-2028)
Figure 37. Asia Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size Market Share by Application (2017-2028)
Figure 38. Asia Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size Share by Region (2017-2028)
Figure 39. China Immune Thrombocytopenic Purpura Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Immune Thrombocytopenic Purpura Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Immune Thrombocytopenic Purpura Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Immune Thrombocytopenic Purpura Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Immune Thrombocytopenic Purpura Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Immune Thrombocytopenic Purpura Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 45. Latin America Immune Thrombocytopenic Purpura Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 46. Latin America Immune Thrombocytopenic Purpura Therapeutics Market Size Market Share by Type (2017-2028)
Figure 47. Latin America Immune Thrombocytopenic Purpura Therapeutics Market Size Market Share by Application (2017-2028)
Figure 48. Latin America Immune Thrombocytopenic Purpura Therapeutics Market Size Share by Country (2017-2028)
Figure 49. Mexico Immune Thrombocytopenic Purpura Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Immune Thrombocytopenic Purpura Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Immune Thrombocytopenic Purpura Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa Immune Thrombocytopenic Purpura Therapeutics Market Size Market Share by Type (2017-2028)
Figure 53. Middle East and Africa Immune Thrombocytopenic Purpura Therapeutics Market Size Market Share by Application (2017-2028)
Figure 54. Middle East and Africa Immune Thrombocytopenic Purpura Therapeutics Market Size Share by Country (2017-2028)
Figure 55. Turkey Immune Thrombocytopenic Purpura Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Immune Thrombocytopenic Purpura Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. UAE Immune Thrombocytopenic Purpura Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Amgen Inc. Revenue Growth Rate in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
Figure 59. Baxalta Incorporated Revenue Growth Rate in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
Figure 60. Boehringer Ingelheim GmbH Revenue Growth Rate in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
Figure 61. Bristol-Myers Squibb Company Revenue Growth Rate in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
Figure 62. Eisai Revenue Growth Rate in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
Figure 63. Hansa Medical AB Revenue Growth Rate in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
Figure 64. Immunomedics, Inc. Revenue Growth Rate in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
Figure 65. Intas Pharmaceuticals Ltd. Revenue Growth Rate in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
Figure 66. Jiangsu Hengrui Medicine Co., Ltd. Revenue Growth Rate in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
Figure 67. Merck & Co., Inc. Revenue Growth Rate in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
Figure 68. Momenta Pharmaceuticals, Inc. Revenue Growth Rate in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
Figure 69. Novartis AG Revenue Growth Rate in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
Figure 70. Pfizer Inc. Revenue Growth Rate in Immune Thrombocytopenic Purpura Therapeutics Business (2017-2022)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.